These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1355396)

  • 1. Neuromuscular blocking agents of intermediate duration in children.
    Shorten G; Goudsouzian N
    Cah Anesthesiol; 1992; 40(3):183-91. PubMed ID: 1355396
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscle relaxants in paediatric day case surgery.
    Meakin GH
    Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 5. Cumulation and flexibility with infusions of neuromuscular blocking drugs.
    Donati F
    Can J Anaesth; 2000 Oct; 47(10):936-42. PubMed ID: 11032266
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vecuronium and atracurium infusions during hypothermic cardiopulmonary bypass.
    Denny NM; Kneeshaw JD
    Anaesthesia; 1986 Sep; 41(9):919-22. PubMed ID: 2877590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
    Booij LH; van Egmond J; van de Pol F; Crul JF
    Eur J Anaesthesiol; 1985 Sep; 2(3):279-84. PubMed ID: 2866094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of atracurium and vecuronium given in continuous injection].
    Neidhardt A; Neidhardt-Audion M; Bachour K
    Cah Anesthesiol; 1984 Dec; 32(8):645-8. PubMed ID: 6152194
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous recovery of neuromuscular function after atracurium in pediatric patients.
    Meretoja OA; Kalli I
    Anesth Analg; 1986 Oct; 65(10):1042-6. PubMed ID: 3755874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is atracurium an ideal neuromuscular blocking drug?
    Miller RD
    Anesth Analg; 1982 Sep; 61(9):721-2. PubMed ID: 6125111
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of neuromuscular block in morbidly obese patients following an infusion of rocuronium.
    Spoelders K; van Duffel L; Vandermeersch E; Adriaenssens G; Van de Velde M
    Acta Anaesthesiol Belg; 2001; 52(3):293-5. PubMed ID: 11732386
    [No Abstract]   [Full Text] [Related]  

  • 19. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of muscle relaxants to the advancement of anaesthetic practice: what is required of new compounds?
    Miller RD; von Ehrenburg W
    Eur J Anaesthesiol Suppl; 1994; 9():1-8. PubMed ID: 7925199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.